Published on in Vol 8 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/42100, first published .
Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview Study

Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview Study

Assessing the Content Validity, Acceptability, and Feasibility of the Hypo-METRICS App: Survey and Interview Study

Uffe Søholm   1, 2, 3 , MD, PhD ;   Natalie Zaremba   3 , MSc ;   Melanie Broadley   2 , PhD ;   Johanne Lundager Axelsen   2 , MSc ;   Patrick Divilly   3 , MD ;   Gilberte Martine-Edith   3 , PhD ;   Stephanie A Amiel   3 , MD, PhD ;   Julia K Mader   4 , MD, PhD ;   Ulrik Pedersen-Bjergaard   5, 6 , MD, PhD ;   Rory J McCrimmon   7 , MD, PhD ;   Eric Renard   8, 9 , MD, PhD ;   Mark Evans   10 , MD ;   Bastiaan de Galan   11, 12, 13 , MD, PhD ;   Simon Heller   14 , MD, PhD ;   Christel Hendrieckx   15, 16 , PhD ;   Pratik Choudhary   3, 17 , MD, PhD ;   Jane Speight   2, 15, 16 , PhD ;   Frans Pouwer   2, 15, 18 , PhD ;   Hypo-RESOLVE consortium Hypo-RESOLVE consortium   19

1 Medical & Science, Patient Focused Drug Development, Novo Nordisk A/S, Søborg, Denmark

2 Department of Psychology, University of Southern Denmark, Odense, Denmark

3 Department of Diabetes, School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences and Medicine, King’s College London, London, United Kingdom

4 Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria

5 Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

6 Department of Endocrinology and Nephrology, Nordsjællands Hospital Hillerød, Hillerød, Denmark

7 Systems Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom

8 Institute of Functional Genomics, University of Montpellier, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Montpellier, France

9 Department of Endocrinology, Diabetes, Nutrition, Montpellier University Hospital, Montpellier, France

10 Welcome-MRC Institute of Metabolic Science and Department of Medicine, University of Cambridge, Cambridge, United Kingdom

11 Department of Internal Medicine, Division of Endocrinology and Metabolic Disease, Maastricht University Medical Centre, Maastricht, Netherlands

12 CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, Netherlands

13 Department of Internal Medicine, Radboud University Medical Centre, Nijmegen, Netherlands

14 Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom

15 School of Psychology, Institute for Health Transformation, Deakin University, Geelong, Australia

16 The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Carlton, Australia

17 Diabetes Research Centre, University of Leicester, Leicester, United Kingdom

18 Steno Diabetes Center Odense, Odense, Denmark

19 See Acknowledgements, Odense, Denmark

Corresponding Author:

  • Uffe Søholm, MD, PhD
  • Medical & Science, Patient Focused Drug Development, Novo Nordisk A/S
  • Vandtårnsvej 114
  • Søborg, 2860
  • Denmark
  • Phone: 45 34481435
  • Email: uffehs@gmail.com